Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach.
- DOI
- 10.1016/j.jval.2026.03.2249
- Published
- 2026 Sep
- Container
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jval.2026.03.2249,
title = {Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach.},
author = {Lund N and Rasche A and Taylor M and Chubb B and Xu W and Taneja L and Olivieri AV and Sharma Y},
year = {2026},
journal = {Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
doi = {10.1016/j.jval.2026.03.2249},
url = {https://doi.org/10.1016/j.jval.2026.03.2249}
}RIS
TY - JOUR TI - Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach. AU - Lund N AU - Rasche A AU - Taylor M AU - Chubb B AU - Xu W AU - Taneja L AU - Olivieri AV AU - Sharma Y PY - 2026 JO - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research DO - 10.1016/j.jval.2026.03.2249 UR - https://doi.org/10.1016/j.jval.2026.03.2249 ER -
APA
N, L., A, R., M, T., B, C., W, X., L, T., AV, O., & Y, S. (2026). Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. https://doi.org/10.1016/j.jval.2026.03.2249
Source records
- pubmed · retrieved 2026-09-26T03:47:55.470Z